Search Results | Frontiers in Pharmaceutical Sciences

Home Results

A total of 6 result was found. Results that relate to Pharmacoeconomic

替雷利珠单抗较索拉非尼作为晚期不可切除肝细胞癌一线治疗的成本-效用分析

SU Zhan CHE Jinhui PEI Ruifeng

DOI：10.12173/j.issn.1008-049X.202312216

Hepatocellular carcinoma Tislelizumab Sorafenib Partition survival model Pharmacoeconomic analysis
Details Download Mobile
阿柏西普对比康柏西普治疗湿性年龄相关性黄斑变性药物经济学评价

LIU Dan ZHANG Bochao ZHANG Jing WANG Juan YUAN Yi GUI Lin CHEN Li

DOI：10.12173/j.issn.1008-049X.202403004

Wet age-related macular degeneration Aflibercept Conbercept Markov model Pharmacoeconomic analysis
Details Download Mobile
基于马尔科夫模型的雷珠单抗或阿柏西普治疗糖尿病性黄斑水肿的成本-效用对比

ZHU Yanxia ZHOU Ruting SHI Tianyan

DOI：10.12173/j.issn.1008-049X.202405025

Diabetic macular edema Aflibercept Ranibizumab Pharmacoeconomics
Details Download Mobile
安罗替尼三线治疗晚期非小细胞肺癌的药物经济学评价

YUAN Wenjie KANG Shuo WANG Xiaohui GONG Yuan PAN Zhenhua

DOI：10.12173/j.issn.2097-0942.202312097

Anlotinib Pharmacoeconomics Non-small cell lung cancer Cost-utility analysis
Details Download Mobile
白蛋白紫杉联合阿替利珠单抗治疗PD-L1阳性晚期乳腺癌成本效用分析

HU Xiuping TAN Lunan LI Hongbo YAO Huitao

DOI：10.12173/j.issn.2097-4922.202503020

Albumin paclitaxel Atezolizumab Pharmacoeconomics Cost-utility analysis
Details Download Mobile
虎地肠溶胶囊治疗溃疡性结肠炎的Meta分析及药物经济学评价

WU Yingxiu ZHONG Jingbin LI Huibiao LIANG Yanzhen REN Jianxiong

DOI：10.12173/j.issn.2097-4922.202605068

Hudi enteric-coated capsules Ulcerative colitis Meta-analysis Pharmacoeconomic Cost-effectiveness analysis
Details Download Mobile